Lufast+ Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the fungal enzyme lanosterol 14α-demethylase, which is essential for ergosterol synthesis, thereby disrupting the fungal cell membrane and leading to cell death. Lufast+ Cream is primarily used in the management of conditions such as tinea corporis, tinea cruris, and tinea pedis. The formulation is intended for topical application to the affected area once daily, providing effective relief from symptoms including itching, redness, and scaling. Clinical studies have demonstrated rapid clinical and mycological cure rates with Luliconazole, often within two weeks of therapy. The cream is generally well tolerated, with minimal adverse effects such as local irritation or burning sensation reported infrequently. It is contraindicated in patients with known hypersensitivity to Luliconazole or any excipients in the formulation. Caution is advised when applying to large areas or broken skin. Lufast+ Cream should be used as directed by a healthcare professional, and treatment duration should be adhered to in order to prevent recurrence and resistance.